GlycoMimetics Enrolls First Patient in Global Phase 3 Clinical Trial of Uproleselan in Relapsed/Refractory Acute Myeloid Leukemia
55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
